Kythera said its ATX-101 injection reached its main and secondary goals in the trials. The drug reportedly worked better than placebo a reducing fat in the submental area of the neck, which can create the appearance of a double chin. ATX-101 is intended to destroy fat cells while leaving other tissue largely unaffected. Read the full story.